Mitomycin is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Mylan Institutional Llc. The primary component is Mitomycin.
| Product ID | 67457-995_96d60181-8337-4bac-99ff-811b836b0112 |
| NDC | 67457-995 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Mitomycin |
| Generic Name | Mitomycin |
| Dosage Form | Injection, Powder, Lyophilized, For Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2017-10-13 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA202670 |
| Labeler Name | Mylan Institutional LLC |
| Substance Name | MITOMYCIN |
| Active Ingredient Strength | 5 mg/10mL |
| Pharm Classes | Alkylating Activity [MoA],Alkylating Drug [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0143-9135 | Mitomycin | Mitomycin |
| 0143-9136 | Mitomycin | Mitomycin |
| 0143-9279 | Mitomycin | Mitomycin |
| 0143-9280 | Mitomycin | Mitomycin |
| 16729-108 | Mitomycin | Mitomycin |
| 16729-115 | Mitomycin | Mitomycin |
| 16729-116 | Mitomycin | Mitomycin |
| 16729-246 | Mitomycin | Mitomycin |
| 16729-247 | Mitomycin | Mitomycin |
| 16729-248 | Mitomycin | Mitomycin |
| 67457-518 | Mitomycin | Mitomycin |
| 67457-519 | Mitomycin | Mitomycin |
| 67457-520 | Mitomycin | Mitomycin |
| 67457-995 | Mitomycin | Mitomycin |
| 67457-996 | Mitomycin | Mitomycin |
| 67457-997 | Mitomycin | Mitomycin |
| 68001-389 | Mitomycin | Mitomycin |
| 68001-390 | Mitomycin | Mitomycin |
| 68001-391 | Mitomycin | Mitomycin |
| 68083-483 | MITOMYCIN | MITOMYCIN |
| 68083-484 | MITOMYCIN | MITOMYCIN |
| 68083-502 | MITOMYCIN | MITOMYCIN |
| 71288-137 | MITOMYCIN | MITOMYCIN |
| 71288-138 | MITOMYCIN | MITOMYCIN |
| 69605-103 | JELMYTO | mitomycin |
| 49771-002 | Mitosol | mitomycin |
| 69448-001 | MUTAMYCIN | Mitomycin |
| 69448-002 | MUTAMYCIN | Mitomycin |
| 69448-003 | MUTAMYCIN | Mitomycin |